Extracorporeal Shockwave Therapy for Knee Osteoarthritis

Knee Osteoarthritis Clinical Trial

Official title:

Extracorporeal Shockwave Therapy for Knee Osteoarthritis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03048773
• Other study ID #: TYGH105013
• Status: Completed
• Phase: N/A
• Start date: March 2, 2017
• Est. completion date: June 30, 2018

Study information

• Verified date: November 2020
• Source: Taoyuan General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Knee osteoarthritis is a common disease that causes joint pain, stiffness, and movement limitation. Nearly 50% in those 75 years and above are affected. In Taiwan, the reported prevalence was more than 6000 per year. The cause of pain is joint instability and structure changed, including hyaline articular cartilage lost, bony remodeling, capsular stretching and periartcular muscle weakness. Current guidelines for treatment of symptomatic knee osteoarthritis include exercise, anti-inflammatory drugs, transcutaneous electrical stimulation(TENS) and magnetic fields(MF) which reduce pain and improve the patient's quality of life. However, conservative therapies and oral supplements have been evaluated but are without clear efficacy. Prolotherapy is an injection therapy for chronic musculoskeletal pain. One of the hypotheses is stimulating local healing and current study demonstrated clinical benefit for pain and improvement of function. The effects of multi-point injections were more pronounced in several studies than single-point injection. Extracorporeal shock wave is common treatment for kidney stones, has been widely used in soft tissue diseases, such as calcified tendon lesions and plantar fasciitis. The theory of extracorporeal shock wave is energy of high-frequency vibration caused destruction of stones and other hard material and by increasing the rate of vascular regeneration in the injured area and increasing the rate of autologous tissue repair, possible biological processes include increased mesenchymal stem cell proliferation and differentiation, slowing the inflammatory response and antimicrobial efficacy. Current studies have shown equivalent clinical outcomes on calcific rotator cuff tendinopathy among extracorporeal shock wave therapy, sono-guided acupuncture and arthroscopic surgery and the extracorporeal shock wave has the advantage of non-invasive treatment. Taking the advantages of non-invasive treatment of extracorporeal shockwave. We want to design a randomized control trial by multi-point shockwave therapy and physical therapy compared with placebo shockwave therapy and physical therapy. Two randomized controlled trial (RCT) reported improvement in outcomes in response to shockwave therapy but were not methodologically rigorous. The investigators therefore conducted a two-arm RCT to assess the hypothesis that adults with symptomatic knee pain receiving shockwave therapy will report greater improvement in knee-related quality-of-life than sham shockwave therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: June 30, 2018
• Est. primary completion date: February 2, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

1. Patient at Taoyuan general hospital rehabilitation outpatient department during 2017/01/01 ~ 2018/12/31

2. Diagnosis with knee osteoarthritis (ACR criteria or Kellgren and Lawrence grading II to IV)

3. Suitable for shockwave therapy and physical therapy with (TENS + MF + stretching + strengthening exercise)

4. Visual analog scale(VAS) ? 4

Exclusion Criteria:

1. Not suitable for shockwave therapy, including acute infection, osteomyelitis, coagulopathy, use of anticoagulants, pregnant women, patients with a pacemaker or implantable cardiac defibrillator

2. Patients who can't understand Chinese, including aphasia or dementia

3. Patient who can't receive 4 weeks of therapy

4. Patient who can't walk due to peripheral neuropathy or central nerve system diseases

5. Total knee arthroplasty

6. Shockwave therapy of knee for the prior 3 months

7. Skin defect or soft tissue infection over symptomatic knee

8. Other cause of knee pain which can't treat with physical therapy, including:

rheumatoid arthritis, infection, fracture, ligament disruption

Related Conditions & MeSH terms

• Knee Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Knee
• Shockwave Therapy

Intervention

Device:
• shockwave therapy
Intervention with shockwave therapy

Other:
• PT
Physical therapy 3 times per week for 3 weeks
• placebo
sham shockwave therapy

Locations

Country	Name	City	State
Taiwan	Taoyuan General Hospital, Ministry of Health and Welfare	Taoyuan

Sponsors (1)

Lead Sponsor	Collaborator
Taoyuan General Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	WOMAC score by Chinese version NRS 3.1		Change from baseline to week 3 and week 4
Primary	six minute walk test	The distance covered in meters of six minute walk test	Change from baseline to week 3 and week 4
Secondary	Visual analog scale (VAS)		Change from baseline to week 3 and week 4